Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | MLYCD | O95822 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12180022 | 0.89 | CYP1A2 (0.38) | CYP1A2ALOX5GAAXDHALDH1A1 | |
| SCHEMBL30195119 | 0.85 | MEN1 (0.54) | CYP1A2ALDH1A1KDM4EHTTPKM | |
| SCHEMBL18694713 | 0.82 | TAS1R3 (0.47) | CYP1A2ALDH1A1KDM4EHTTMEN1 | |
| SCHEMBL27201021 | 0.81 | CYP1A2 (0.37) | CYP1A2ALDH1A1KDM4EHTTACE2 | |
| SCHEMBL9511408 | 0.81 | CYP1A2 (0.39) | CYP1A2ALDH1A1KDM4EACE2MEN1 | |
| SCHEMBL30101142 | 0.80 | CYP1A2 (0.54) | CYP1A2GAAALDH1A1KMT2A | |
| SCHEMBL11520918 | 0.80 | CYP1A2 (0.54) | CYP1A2GAAALDH1A1KMT2A | |
| SCHEMBL2100060 | 0.80 | CYP1A2 (0.54) | CYP1A2GAAALDH1A1KMT2A | |
| SCHEMBL823153 | 0.80 | CYP1A2 (0.54) | CYP1A2GAAALDH1A1KMT2A | |
| SCHEMBL30141 | 0.79 | CYP1A2 (0.78) | CYP1A2GAAALDH1A1KDM4EACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530270-B2 | Methods of preparing semiconductive compositions and devices | EASTMAN KODAK COMPANY (US) | 2013-09-10 | — | — | US | disclosed |
| US-8411489-B2 | Semiconducting devices and methods of preparing | EASTMAN KODAK COMPANY (US) | 2013-04-02 | — | — | US | disclosed |
| US-8314265-B2 | Aromatic amic acids or amic esters and compositions | EASTMAN KODAK COMPANY (US) | 2012-11-20 | — | — | US | disclosed |
| US-20110269967-A1 | AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS | BANK OF AMERICA, N.A., AS AGENT | 2011-11-03 | — | — | US | disclosed |
| US-20110269966-A1 | SEMICONDUCTING ARTICLES | CITICORP NORTH AMERICA, INC., AS AGENT | 2011-11-03 | — | — | US | disclosed |
| US-20110266523-A1 | SEMICONDUCTING DEVICES AND METHODS OF PREPARING | BANK OF AMERICA, N.A., AS AGENT | 2011-11-03 | — | — | US | disclosed |
| US-20110269265-A1 | METHODS OF PREPARING SEMICONDUCTIVE COMPOSITIONS AND DEVICES | KODAK REALTY INC. | 2011-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269966-A1 | SEMICONDUCTING ARTICLES | ALAD, PORCN, DDC | CYP1A2 498/4885ALOX5 118/4885GAA 2404/4885 |
| US-20110269967-A1 | AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS | DDC, AADAC, MYOC | CYP1A2 155/4885ALOX5 1502/4885GAA 2124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.